Variant report
Variant | esv3319227 |
---|---|
Chromosome Location | chr19:51508433-51511726 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:19)
- CpG islands (count:63)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:19 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr19:51508320-51508470 | GM12871 | blood: | n/a | n/a |
2 | CTCF | chr19:51508482-51508582 | Lung_OC | lung: | n/a | n/a |
3 | CTCF | chr19:51511053-51511112 | GM10266 | blood: | n/a | n/a |
4 | ELF1 | chr19:51509795-51510060 | K562 | blood: | n/a | n/a |
5 | HDAC2 | chr19:51510795-51510997 | K562 | blood: | n/a | n/a |
6 | JUN | chr19:51509803-51509939 | HepG2 | liver: | n/a | chr19:51509838-51509851 |
7 | JUN | chr19:51509656-51509821 | K562 | blood: | n/a | n/a |
8 | JUND | chr19:51509715-51510011 | HepG2 | liver: | n/a | n/a |
9 | JUND | chr19:51509760-51509880 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | JUND | chr19:51509785-51509985 | K562 | blood: | n/a | n/a |
11 | POLR2A | chr19:51508881-51508928 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | RCOR1 | chr19:51510735-51511119 | K562 | blood: | n/a | n/a |
13 | RCOR1 | chr19:51508562-51508762 | K562 | blood: | n/a | n/a |
14 | RCOR1 | chr19:51510839-51511075 | K562 | blood: | n/a | n/a |
15 | RCOR1 | chr19:51508526-51508899 | K562 | blood: | n/a | n/a |
16 | ZNF143 | chr19:51510775-51511052 | H1-hESC | embryonic stem cell: | n/a | chr19:51510931-51510950 chr19:51510932-51510947 |
17 | ZNF143 | chr19:51508525-51508873 | K562 | blood: | n/a | chr19:51508696-51508715 chr19:51508697-51508712 |
18 | ZNF143 | chr19:51508549-51508749 | H1-hESC | embryonic stem cell: | n/a | chr19:51508696-51508715 chr19:51508697-51508712 |
19 | ZNF143 | chr19:51510786-51511086 | K562 | blood: | n/a | chr19:51510931-51510950 chr19:51510932-51510947 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:51508927-51508977 | AoSMC | blood vessel: | n/a |
2 | chr19:51508927-51508977 | H1-hESC | embryonic stem cell: | embryo |
3 | chr19:51508927-51508977 | AoSMC | blood vessel: | n/a |
4 | chr19:51508927-51508977 | H1-hESC | embryonic stem cell: | embryo |
5 | chr19:51508927-51508977 | SAEC | small airway: | n/a |
6 | chr19:51508927-51508977 | AG09309 | skin: | n/a |
7 | chr19:51508927-51508977 | CMK | blood: | n/a |
8 | chr19:51508927-51508977 | NHBE | bronchial: | n/a |
9 | chr19:51508927-51508977 | GM12891 | blood: | n/a |
10 | chr19:51508927-51508977 | AG09319 | gingival: | n/a |
11 | chr19:51508927-51508977 | IMR90 | lung: | fetal |
12 | chr19:51508927-51508977 | HMEC | breast: | n/a |
13 | chr19:51508927-51508977 | HRPEpiC | eye: | n/a |
14 | chr19:51508927-51508977 | K562 | blood: | n/a |
15 | chr19:51508927-51508977 | HUVEC | blood vessel: | n/a |
16 | chr19:51508927-51508977 | GM12878 | blood: | n/a |
17 | chr19:51508927-51508977 | ovcar-3 | ovarian: | n/a |
18 | chr19:51508927-51508977 | AG04449 | skin: | fetal |
19 | chr19:51508927-51508977 | GM19239 | blood: | n/a |
20 | chr19:51508927-51508977 | GM12892 | blood: | n/a |
21 | chr19:51508927-51508977 | MCF-7 | breast: | n/a |
22 | chr19:51508927-51508977 | PFSK-1 | brain: | n/a |
23 | chr19:51508927-51508977 | SKMC | muscle: | n/a |
24 | chr19:51508927-51508977 | HNPCEpiC | eye: | n/a |
25 | chr19:51508927-51508977 | HCT-116 | colon: | n/a |
26 | chr19:51508927-51508977 | HIPEpiC | eye: | n/a |
27 | chr19:51508927-51508977 | ECC-1 | luminal epithelium: | n/a |
28 | chr19:51508927-51508977 | HEEpiC | esophagus: | n/a |
29 | chr19:51508927-51508977 | NB4 | blood: | n/a |
30 | chr19:51508927-51508977 | HPAEpiC | pulmonary alveolar: | n/a |
31 | chr19:51508927-51508977 | T-47D | breast: | n/a |
32 | chr19:51508927-51508977 | HCPEpiC | choroid plexus: | n/a |
33 | chr19:51508927-51508977 | BE2_C | brain: | n/a |
34 | chr19:51508927-51508977 | HL-60 | blood: | n/a |
35 | chr19:51508927-51508977 | HCF | heart: | n/a |
36 | chr19:51508927-51508977 | HAEpiC | amniotic membrane: | n/a |
37 | chr19:51508927-51508977 | SK-N-MC | brain: | n/a |
38 | chr19:51508927-51508977 | U87 | brain: | n/a |
39 | chr19:51508927-51508977 | HRCEpiC | kidney: | n/a |
40 | chr19:51508927-51508977 | AG04450 | lung: | fetal |
41 | chr19:51508927-51508977 | RPTEC | kidney: | n/a |
42 | chr19:51508927-51508977 | Jurkat | blood: | n/a |
43 | chr19:51508927-51508977 | GM06990 | blood: | n/a |
44 | chr19:51508927-51508977 | NHDF-neo | bronchial: | n/a |
45 | chr19:51508927-51508977 | Caco-2 | colon: | n/a |
46 | chr19:51508927-51508977 | SK-N-SH_RA | brain: | n/a |
47 | chr19:51508927-51508977 | SK-N-SH | brain: | n/a |
48 | chr19:51508927-51508977 | A549 | lung: | n/a |
49 | chr19:51508927-51508977 | ProgFib | skin: | n/a |
50 | chr19:51508927-51508977 | PANC-1 | pancreas: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KLK8 | TF binding region |
ENSG00000269741 | TF binding region |
KLK8 | CpG island |
ENSG00000269741 | CpG island |
ENSG00000213022 | chromatin interactions |
ENSG00000268739 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115883102 | chr19:51508456-51508457 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs377343171 | chr19:51508464-51508465 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs566741046 | chr19:51508499-51508500 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs80253708 | chr19:51508519-51508520 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs553268643 | chr19:51508580-51508581 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs2569473 | chr19:51508621-51508622 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs577700424 | chr19:51508627-51508628 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs187191037 | chr19:51508703-51508704 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs113916351 | chr19:51508713-51508714 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs11672663 | chr19:51508721-51508722 | Weak transcription | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs538410748 | chr19:51508723-51508724 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs556789923 | chr19:51508749-51508750 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs575251653 | chr19:51508775-51508776 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs181163991 | chr19:51508860-51508861 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs10401205 | chr19:51508886-51508887 | Weak transcription | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs373760666 | chr19:51508894-51508895 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs10426081 | chr19:51508896-51508897 | Weak transcription | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs540957119 | chr19:51508927-51508928 | Weak transcription | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs199549709 | chr19:51508978-51508979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113915632 | chr19:51508984-51508985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577532552 | chr19:51509035-51509036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544752621 | chr19:51509078-51509079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs137993095 | chr19:51509109-51509110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530251549 | chr19:51509119-51509120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11673588 | chr19:51509158-51509159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560139674 | chr19:51509161-51509162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs200118661 | chr19:51509180-51509181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144461714 | chr19:51509189-51509190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562144225 | chr19:51509190-51509191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533715288 | chr19:51509192-51509193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191664749 | chr19:51509215-51509216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200310627 | chr19:51509279-51509280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561180999 | chr19:51509290-51509291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs370345510 | chr19:51509328-51509329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571167764 | chr19:51509339-51509340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183499733 | chr19:51509340-51509341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs150507579 | chr19:51509366-51509367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113832971 | chr19:51509381-51509382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370163597 | chr19:51509382-51509383 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs60620559 | chr19:51509410-51509411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542339922 | chr19:51509445-51509446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568561524 | chr19:51509452-51509453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138674427 | chr19:51509476-51509477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs373762977 | chr19:51509501-51509502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573024555 | chr19:51509523-51509524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185356028 | chr19:51509527-51509528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537527492 | chr19:51509548-51509549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533738181 | chr19:51509584-51509585 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs559306074 | chr19:51509589-51509590 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs78981292 | chr19:51509595-51509596 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:51506000-51509200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr19:51506000-51509600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr19:51506200-51509600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr19:51506200-51509600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr19:51506400-51509400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr19:51506400-51509400 | Weak transcription | HMEC | breast |
7 | chr19:51506400-51509600 | Weak transcription | NHEK | skin |
8 | chr19:51507200-51512400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr19:51509200-51510600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr19:51509400-51510200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr19:51509400-51510800 | Enhancers | HMEC | breast |
12 | chr19:51509600-51510200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
13 | chr19:51509600-51510200 | Enhancers | NHEK | skin |
14 | chr19:51509600-51510400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr19:51509600-51510400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr19:51510200-51512000 | Weak transcription | NHEK | skin |
17 | chr19:51510200-51512400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr19:51510200-51517000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
19 | chr19:51510400-51512200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
20 | chr19:51510600-51512200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
21 | chr19:51510800-51512000 | Weak transcription | HMEC | breast |